Free Research Report on ABIOMED, Inc., Acco Brands Corp., Acorda Therapeutics, Inc., Addus HomeCare Corp and First Majestic Silver Corp.

Thu Jan 31, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130131:nPn1313024


NEW YORK,  January 31, 2013  /PRNewswire/ --

Today, Traders Insight announced new research reports highlighting ABIOMED, Inc.
(Nasdaq: ABMD), Acco Brands Corp. (NYSE: ACCO), Acorda Therapeutics, Inc.
(Nasdaq: ACOR), Addus HomeCare Corp (Nasdaq: ADUS) and First Majestic Silver
Corp. (NYSE: AG). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.


ABIOMED, Inc. Research Report

ABIOMED, Inc. develops temporary and permanent cardiac support systems. The
Company develops, manufactures and markets medical technologies designed to
assist or replace the pumping function of the failing heart. It focuses on the
development of two temporary support systems, the bi-ventricular support system
(BVS) and the intra-arterial cardiac support system (ICs). The Full Research
Report on ABIOMED, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/2439_ABMD]

Acco Brands Corp. Research Report

ACCO Brands Corporation is a supplier of office products to the office products
resale industry. The Company designs, develops, manufactures and markets a
variety of traditional and computer-related office products, supplies, binding
and laminating equipment and related consumable supplies, personal computer
accessory products, paper-based time management products and presentation aids
and products. The Full Research Report on Acco Brands Corp. - including full
detailed breakdown, analyst ratings and price targets - is available to download
free of charge at: [http://www.TradersInsight.net/r/2013-01-30/ad82_ACCO]

Acorda Therapeutics, Inc. Research Report

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical
company. The Company is engaged in the identification, development and
commercialization of novel therapies that improve neurological function in
people with multiple sclerosis (MS), spinal cord injury (SCI), and other
disorders of the nervous system. Ampyra (dalfampridine) is an extended release
tablet formulation of dalfampridine (4-aminopyridine, 4-AP). The Full Research
Report on Acorda Therapeutics, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/fe67_ACOR]

Addus HomeCare Corp Research Report

Addus HomeCare Corporation is a provider of a range of social and medical
services in the home focused primarily on the dual eligible population. The
Company operates in two segments: home & community services and home health
services. The Company's services include personal care and assistance with
activities of daily living, skilled nursing and rehabilitative therapies, and
adult day care. The Full Research Report on Addus HomeCare Corp - including full
detailed breakdown, analyst ratings and price targets - is available to download
free of charge at: [http://www.TradersInsight.net/r/2013-01-30/9261_ADUS]

First Majestic Silver Corp. Research Report

First Majestic Silver Corp. (First Majestic), is engaged in the business of
silver production, development, exploration, and acquisition of mineral
properties with a focus on silver production in  Mexico. The Company has three
operating segments located in  Mexico, two development projects in  Mexico, one
retail market segment in  Canada  and one silver trading segment in  Europe. The
Full Research Report on First Majestic Silver Corp. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.TradersInsight.net/r/2013-01-30/2ab7_AG]


About Traders Insight

Our model of enabling open collaboration between members is breaking new ground
into the investment community. By tapping into the resources of the community,
we are crowd-sourcing our reach. As a result -- we have been able to identify
some of the greatest moving companies on the market today. The evidence is in
the results, join today and experience what you've been missing.



Press Contact:

Cora S. Patton
press@TradersInsight.net

+1-203-297-6092 (North America)


SOURCE  Traders Insight

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.